Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. (2021)

First Author: Kalil AC
Attributed to:  Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2031994

PubMed Identifier: 33306283

Publication URI: http://europepmc.org/abstract/MED/33306283

Type: Journal Article/Review

Volume: 384

Parent Publication: The New England journal of medicine

Issue: 9

ISSN: 0028-4793